I recommend waiting for a better discount before investing in Akoustis Technologies Inc. (AKTS).

The price of Akoustis Technologies Inc. (NASDAQ: AKTS) closed at $3.02 in the last session, up 2.72% from day before closing price of $2.94. In other words, the price has increased by $+0.0800 from its previous closing price. On the day, 4595846 shares were traded. AKTS stock price reached its highest trading level at $3.1200 during the session, while it also had its lowest trading level at $2.8300.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



We take a closer look at AKTS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.40 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.51.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on February 02, 2021, Reiterated its Buy rating but revised its target price to $20 from $18 previously.

On January 15, 2021, Craig Hallum reiterated its Buy rating and also lowered its target price recommendation from $12 to $18.

Northland Capital Downgraded its Outperform to Market Perform on September 18, 2019, while the target price for the stock was maintained at $7.40.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 20 when Shealy Jeffrey B. sold 2,340 shares for $2.84 per share. The transaction valued at 6,646 led to the insider holds 505,502 shares of the business.

Boller Kenneth sold 1,200 shares of AKTS for $3,504 on Dec 19. The CFO now owns 111,758 shares after completing the transaction at $2.92 per share. On Dec 19, another insider, Aichele David, who serves as the EVP of Business Development of the company, sold 1,480 shares for $3.14 each. As a result, the insider received 4,647 and left with 215,987 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 8.89 while its Price-to-Book (P/B) ratio in mrq is 1.99.

Stock Price History:

Over the past 52 weeks, AKTS has reached a high of $7.13, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 3.2985, while the 200-Day Moving Average is calculated to be 3.8019.

Shares Statistics:

According to the various share statistics, AKTS traded on average about 425.45K shares per day over the past 3-months and 1.02M shares per day over the past 10 days. A total of 57.15M shares are outstanding, with a floating share count of 54.83M. Insiders hold about 3.90% of the company’s shares, while institutions hold 49.90% stake in the company. Shares short for AKTS as of Oct 13, 2022 were 4.92M with a Short Ratio of 4.92M, compared to 5.29M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.58% and a Short% of Float of 8.91%.

Earnings Estimates

The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.25, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.1 and low estimates of -$0.24.

Analysts are recommending an EPS of between -$0.33 and -$0.98 for the fiscal current year, implying an average EPS of -$0.77. EPS for the following year is -$0.52, with 4 analysts recommending between -$0.03 and -$0.87.

Revenue Estimates

According to 4 analysts, the current quarter’s revenue is expected to be $5.56M. It ranges from a high estimate of $5.66M to a low estimate of $5.5M. As of the current estimate, Akoustis Technologies Inc.’s year-ago sales were $2.01M, an estimated increase of 176.60% from the year-ago figure.

A total of 4 analysts have provided revenue estimates for AKTS’s current fiscal year. The highest revenue estimate was $30M, while the lowest revenue estimate was $26.5M, resulting in an average revenue estimate of $28.49M. In the same quarter a year ago, actual revenue was $15.35M, up 85.60% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $58.37M in the next fiscal year. The high estimate is $72M and the low estimate is $50M. The average revenue growth estimate for next year is up 104.90% from the average revenue estimate for this year.